| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |